knowledge -WSS

knowledge

author：hotspot 2025-09-06 03:53:25 - browse：4

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： The U.S. needs a new definition of substance use “recovery”

Wikipedia

WSS

Drinking water from half of US faucets contains PFAS: Study

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Create a giant ice tray with this foil pan hack to keep food cold this summer

Neutralizing antibodies against HIV shows promise in children

The U.S. needs a new definition of substance use “recovery”

hotspot

knowledge

entertainment

Supreme Court strikes down use of affirmative action

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Hepatitis C has a cure — but many Americans still lack access to it

Home health providers sue Medicare over payment cuts

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Trump demands the U.S. pay no more for drugs than other countries … again

Eisai exec who led development of Alzheimer’s drug to retire

After affirmative action ruling, medical educators look to 'holistic review'

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

focus

Parents surprise family after baby discharged from NICU after 170 days

Sen. Bill Cassidy on how to lower drug prices

UPS workers' union leader explains what's at stake as strike edges closer

Neutralizing antibodies against HIV shows promise in children

The PBM ad wars are taking over Washington, D.C.

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

entertainment

hotspot

Wikipedia

hotspot